1. Armstrong RD, Diasio RB (1980) Metabolism and biological activity of 5′-deoxy-5-fluorouridine, a novel fluoropyrimidine. Cancer Res 40:3333–33338
2. Baek IH, Chae JW, Chae HJ, Kwon KI (2010) Development and validation of a robust LC–MS/MS method for the simultaneous quantification of doxifluridine and its two metabolites in beagle dog plasma. Bull Korean Chem Soc 31:36–42
3. Bollag W, Hartmann HR (1980) Tumor inhibitory effects of a new fluorouracil derivative: 5′-deoxy-5-fluorouridine. Eur J Cancer 16:427–432
4. Brusa P, Dosio F, Coppo S, Pacchioni D, Arpicco S, Crosasso P, Cattel L (1997) In vitro and in vivo antitumor activity of immunoconjugates prepared by linking 5-fluorouridine to antiadenocarcinoma monoclonal antibody. Farmaco 52:71–81
5. D’Argenio DZ, Schumitzky A (1997) ADAPT II User’s Guide: Pharmacokinetic/Pharmacodynamic Systems Analysis Software. Biomedical Simulations Resource, Los Angeles